Table 2.

Patients characteristics (N = 36)

Patient characteristicsNumber
Median age, years (range)56 (19–75)
Gender, N (%)
 Male12 (33)
 Female24 (67)
Ethnicity, N (%)
 White22 (61)
 African-American5 (14)
 Hispanic4 (11)
 Other5 (14)
ECOG performance status, N (%)
 06 (17)
 127 (75)
 23 (8)
Prior therapies
 Median prior therapies, N (range)3 (0–9)
 <5 therapies, N (%)25 (69)
 ≥ 5 therapies, N (%)11 (31)
 Prior ipilimumab, N (%)3 (8)
 Prior lenalidomide, N (%)1 (3)
 Prior allogenic stem cell transplant (%)4 (11)
Diagnosis, N (%)
 Melanoma5 (14)
 Thyroid cancer3 (8)
 Adrenocortical cancer2 (6)
 Adenoid cystic cancer2 (6)
 Leiomyosarcoma4 (11)
 Hodgkin Lymphoma7 (19)
 Renal cancer3 (8)
 Other (cervical, colorectal, peritoneal, ovarian, triple-negative breast, squamous cell head and neck, chondrosarcoma, osteosarcoma, carcinosarcoma, and teratoma)10 (28)